Comparative proteomic analysis of matched primary and metastatic melanoma cell lines

Journal of Proteome Research

Volumn 7, Issue 9, 2008, Pages 4107-4118

  Al Ghoul, Mohammad ^a,b   Brück, Thomas B ^a,c   Lauer Fields, Janelle L ^a   Asirvatham, Victor S ^a   Zapata, Claudia ^a   Kerr, Russell G ^d   Fields, Gregg B ^a  

^a FLORIDA ATLANTIC UNIVERSITY   (United States)

^b University of Louisville School of Medicine   (United States)

^c SÜD CHEMIE AG   (Germany)

^d UNIVERSITY OF PRINCE EDWARD ISLAND   (Canada)

Author keywords

Cyclophilin; Melanoma; Melanoma progression; Melanoma proteomics

Indexed keywords

CYCLOPHILIN A; PROTEOME; TUMOR PROTEIN;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; HUMAN CELL; MELANOMA CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DATABASE; PROTEIN ISOLATION; PROTEOMICS; TIME OF FLIGHT MASS SPECTROMETRY; UNINDEXED SEQUENCE; COMPARATIVE STUDY; FEMALE; LIQUID CHROMATOGRAPHY; MELANOMA; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; PEPTIDE MAPPING; TANDEM MASS SPECTROMETRY; TUMOR CELL LINE; TWO DIMENSIONAL GEL ELECTROPHORESIS;

CELL LINE, TUMOR; CHROMATOGRAPHY, LIQUID; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; MELANOMA; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM PROTEINS; PEPTIDE MAPPING; PROTEOME; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY;

EID: 55249105481     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr800174k     Document Type: Article

References (45)

1. Bernard, K.; Litman, E.; Fitzpatrick, J. L.; Shellman, Y. G.; Argast, G.; Polvinen, K.; Everett, A. D.; Fukasawa, K.; Norris, D. A.; Ahn, N. G.; Resing, K. A. Functional proteomic analysis of melanoma progression. Cancer Res. 2003, 63, 6716-6725.
2. U.S. National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Registry; 2007.
3. American Cancer Society Cancer Facts & Figures 2004;http://www. cancer.org, 2004.
4. de Souza, G. A.; Godoy, L. M.; Teixeira, V. R.; Otake, A. H.; Sabino, A.; Rosa, J. C; Dinarte, A. R.; Pinheiro, D. G.; Silva, W. A., Jr.; Eberlin, M. N.; Chammas, R.; Greene, L. J. Proteomic and SAGE profiling of murine melanoma progression indicates the reduction of proteins responsible for ROS degradation. Proteomics 2006, 6, 1460-1470.
5. Smalley, K. S.; Herlyn, M. Targeting intracellular signaling pathways as a novel strategy in melanoma therapeutics. Ann. N. Y. Acad. Sci. 2005, 1059, 16-25.
6. Mozzillo, N.; Nunziata, C. A.; Caraco, C; Fazioli, F.; Botti, G. Malignant melanoma developing in an area of hereditary palmoplantar keratoderma (Mai de Meleda). J. Surg. Oncol. 2003, 84, 229-233.
7. Chin, L. The genetics of malignant melanoma: lessons from mouse and man. Nat. Rev. Cancer 2003, 3, 559-570.
8. Carta, F.; Demuro, P. P.; Zanini, C; Santona, A.; Castiglia, D.; D'Atri, S.; Ascierto, P. A.; Napolitano, M.; Cossu, A.; Tadolini, B.; Turrini, F.; Manca, A.; Sini, M. C; Palmieri, G.; Rozzo, C. Analysis of candidate genes through a proteomics-based approach in primary cell lines from malignant melanomas and their metastases. Melanoma Res. 2005, 15, 235-244.
9. Culp, W. D.; Neal, R.; Massey, R.; Egevad, L.; Pisa, P.; Garland, D. Proteomic analysis of tumor establishment and growth in the B16-F10 mouse melanoma model. J. Proteome Res. 2006, 5, 1332-1343.
10. DeRisi, J.; Penland, L.; Brown, P. O.; Bittner, M. L.; Meltzer, P. S.; Ray, M.; Chen, Y.; Su, Y. A.; Trent, J. M. Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat. Genet. 1996, 14, 457-460.
11. Clark, E. A.; Golub, T. R.; Lander, E. S.; Hynes, R. O. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 2000, 406, 532-535.
12. Baldi, A.; Battista, T.; De Luca, A.; Santini, D.; Rossiello, L.; Baldi, F.; Natali, P. G.; Lombardi, D.; Picardo, M.; Felsani, A.; Paggi, M. G. Identification of genes down-regulated during melanoma progression: a cDNA array study. Exp. Dermatol. 2003, 12, 213-218.
13. Haqq, C; Nosrati, M.; Sudilovsky, D.; Crothers, J.; Khodabakhsh, D.; Pulliam, B. L.; Federman, S.; Miller, J. R., 3rd; Allen, R. E.; Singer, M. I.; Leong, S. P.; Ljung, B. M.; Sagebiel, R. W.; Kashani-Sabet, M. The gene expression signatures of melanoma progression. Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 6092-6097.
14. Hoek, K. S. DNA microarray analyses of melanoma gene expression: A decade in the mines. Pigment Cell Res. 2007, 20, 466-484.
15. Torabian, S.; Kashani-Sabet, M. Biomarkers for melanoma. Curr. Opin. Oncol. 2005, 17, 167-171.
16. Pardo, M.; Garcia, A.; Thomas, B.; Pineiro, A.; Akoulitchev, A.; Dwek, R. A.; Zitzmann, N. Proteome analysis of a human uveal melanoma primary cell culture by 2DE and MS. Proteomics 2005, 5, 4980-4993.
17. Afjehi-Sadat, L.; Shin, J. H.; Felizardo, M.; Lee, K.; Slavc, I.; Lubec, G. Detection of hypothetical proteins in 10 individual human tumor cell lines. Biochim. Biophys. Acta 2005, 1747, 67-80.
18. Zuidervaart, W.; Hensbergen, P. J.; Wong, M. C.; Deelder, A. M.; Tensen, C. P.; Jager, M. J.; Gruis, N. A. Proteomic analysis of uveal melanoma reveals novel potential markers involved in tumor progression. Invest. Ophthalmol. Vis. Sci. 2006, 47, 786-793.
19. Sinha, P.; Poland, J.; Kohl, S.; Schnolzer, M.; Helmbach, H.; Hutter, G.; Lage, H.; Schadendorf, D. Study of the development of chemoresistance in melanoma cell lines using proteome analysis. Electrophoresis 2003, 24, 2386-2404.
20. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248-254.
21. Candiano, G.; Bruschi, M.; Musante, L.; Santucci, L.; Ghiggeri, G. M.; Carnemolla, B.; Orecchia, P.; Zardi, L.; Righetti, P. G. Blue silver: A very sensitive colloidal Coomassie G-250 staining for proteome analysis. Electrophoresis 2004, 25, 1327-1333.
22. Yuan, J.; Wang, B.; Sun, Z.; Bo, X.; Yuan, X.; He, X.; Zhao, H.; Du, X.; Wang, F.; Jiang, Z.; Zhang, L.; Jia, L.; Wang, Y.; Wei, K.; Wang, J.; Zhang, X.; Sun, Y.; Huang, L.; Zeng, M. Analysis of Host-Inducing Proteome Changes in Bifidobacterium longum NCC2705 Grown in Vivo. J. Proteome Res. 2008, 7, 375-385.
23. Bruno, P. M.; Van Dyk, D.; Cole, R.; Knuckey, N. W. Proteome analysis of cortical neuronal cultures following cycloheximide, heat stress and MK801 preconditioning. Proteomics 2005, 5, 4743-4753.
24. Alete, D. E.; Racher, A. J.; Brich, J. R.; Stansfield, S. H.; James, D. C; Smales, C. M. Proteomic analysis of enriched microsomal fractions from GS-NS0 murine myeloma cells with varying sectreted recombinant monoclonal antibody productivities. Proteomics 2005, 5, 4689-4704.
25. Schuemie, M.; Chichester, C; Lisacek, F.; Coute, Y.; Roes, P.-J.; Sanchez, J. C; Kors, J.; Mons, B. Assignment of protein function and discovery of novel nucleolar proteins based on automatic analysis of MEDLINE. Proteomics 2007, 7, 921-931.
26. Mawuenyega, K. G.; Kaji, H.; Yamauchi, Y.; Shinkawa, T.; Saito, H.; Taoka, M.; Takahashi, N.; Isobe, T. Large-Scale Identification of Caenorhabditis elegans Proteins by Multidimensional Liquid Chromatography-Tandem Mass Spectrometry. J. Proteome Res. 2003, 2, 23-35.
27. Lee, C.-L.; Hsiao, H.-H.; Lin, C.-W.; Wu, S.-P.; Huang, S.-Y.; Wu, C.-Y.; Wang, A. H.-J.; Khoo, K.-H. Strategic shotgun proteomics approach for efficient construction of an expression map of targeted protein families in hepatoma cell lines. Proteomics 2003, 3, 2472-2486.
28. O'Neil, K. A.; Miller, F. R.; Barder, T. J.; Lubman, D. M. Profiling the progression of cancer: Separation of microsomal proteins in MCF10 breast epithelial cell lines using nonporous chromatophoresis. Proteomics 2003, 3, 1256-1269.
29. Resing, K. A.; Meyer-Arendt, K.; Mendoza, A. M.; Aveline-Wolf, L. D.; Jonscher, K. R.; Pierce, K. G.; Old, W. M.; Cheung, H. T.; Russell, S.; Wattawa, J. L.; Goehle, G. R.; Knight, R. D.; Ann, N. G. Improving Reproducibility and Sensitivity in Identifying Human Proteins by Shotgun Proteomics. Anal. Chem. 2004, 76, 3556-3568.
30. Rubinstein, N.; Alvarez, M.; Zwirner, N. W.; Toscano, M. A.; Ilarregui, J. M.; Bravo, A.; Mordoh, J.; Fainboim, L.; Podhajcer, O. L.; Rabinovich, G. A. Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; A potential mechanism of tumor-immune privilege. Cancer Cell 2004, 5, 241-251.
31. Kim, H.; Kim, W. J.; Jeon, S. T.; Koh, E. M.; Cha, H. S.; Ahn, K. S.; Lee, W. H. Cyclophilin A may contribute to the inflammatory processes in rheumatoid arthritis through induction of matrix degrading enzymes and inflammatory cytokines from macrophages. Clin. Immunol. 2005, 116, 217-224.
32. Lubec, G.; Afjehi-Sadat, L. Limitations and pitfalls in protein identification by mass spectrometry. Chem. Rev. 2007, 107, 3568-3584.
33. Qi, W.; Liu, X.; Qiao, D.; Martinez, J. D. Isoform-specific expression of 14-3-3 proteins in human lung cancer tissues. Int. J. Cancer 2005, 113, 359-363.
34. Li, M.; Zhai, Q.; Bharadwaj, U.; Wang, H.; Li, F.; Fisher, W. E.; Chen, C; Yao, Q. Cyclophilin A is overexpressed in human pancreatic cancer cells and stimulates cell proliferation through CD147. Cancer 2006, 106, 2284-2294.
35. Mikuriya, K.; Kuramitsu, Y.; Ryozawa, S.; Fujimoto, M.; Mori, S.; Oka, M.; Hamano, K.; Okita, K.; Sakaida, I.; Nakamura, K. Expression of glycolytic enzymes is increased in pancreatic cancerous tissues as evidenced by proteomic profiling by two-dimensional electrophoresis and liquid chromatography-mass spectrometry/mass spectrometry. Int. J. Oncol. 2007, 30, 849-855.
36. Fu, H.; Subramanian, R. R.; Masters, S. C. 14-3-3 proteins: Structure, function, and regulation. Annu. Rev. Pharmacol. Toxicol. 2000, 40, 617-647.
37. Chuang, J. Z.; Milner, T. A.; Zhu, M.; Sung, C. H. A 29 kDa intracellular chloride channel p64H1 is associated with large dense-core vesicles in rat hippocampal neurons. J Neurosci. 1999, 19, 2919-2928.
38. Suh, K. S.; Mutoh, M.; Gerdes, M.; Yuspa, S. H. CLIC4, an intracellular chloride channel protein, is a novel molecular target for cancer therapy. J. Invest. Dermatol. Symp. Proc. 2005, 10, 105-109.
39. Suginta, W.; Karoulias, N.; Aitken, A.; Ashley, R. H. Chloride intracellular channel protein CLIC4 (p64H1) binds directly to brain dynamin I in a complex containing Actin, tubulin and 14-3-3 isoforms. Biochem. J. 2001, 359, 55-64.
40. Pap, T. Cyclophilins in rheumatoid arthritis-stepping into an undiscovered country. Clin. Immunol. 2005, 116, 199-201.
41. Howard, B. A.; Furumai, R.; Campa, M. J.; Rabbani, Z. N.; Vujaskovic, Z.; Wang, X. F.; Patz, E. F., Jr. Stable RNA interference-mediated suppression of cyclophilin A diminishes non-small-cell lung tumor growth in vivo. Cancer Res. 2005, 65, 8853-8860.
42. Morvillo, V.; Bover, L.; Mordoh, J. Identification and characterization of a 14 kDa immunosuppressive protein derived from IIBMEL-J, a human melanoma cell line. Cell Mol. Biol. 1996, 42, 779-795.
43. Ciechomska, I.; Legat, M.; Golab, J.; Wesolowska, A.; Kurzaj, Z.; Mackiewicz, A.; Kaminska, B. Cyclosporine A and its non-immunosuppressive derivative NIM811 induce apoptosis of malignant melanoma cells in in vitro and in vivo studies. Int. J. Cancer 2005, 117, 59-67.
44. Semba, S.; Huebner, K. Protein expression profiling identifies cyclophilin A as a molecular target in Fhit-mediated tumor suppression. Mol. Cancer Res. 2006, 4, 529-538.
45. Conner, G. E., Cathepsin D. In Handbook of Proteolytic Enzymes, 2nd ed.; Barrett, A. J., Rawlings, N. D., Woessner, J. F., Eds.; Elsevier Academic Press: London, 2004; pp 43-52.